Biaxin XL (R) (Clarithromycin extended-release tablets) and Levaquin(R) achieve similar results for community-acquired pneumonia

San Francisco, Calif., May 23, 2001 A new study comparing Biaxin XL(R) (clarithromycin extended-release tablets) and another leading, once-daily antibiotic, Levaquin(R) (levofloxacin tablets, Johnson & Johnson) shows that Biaxin XL and Levaquin had similar results in patients with community-acquired pneumonia (CAP). The results presented today at the 97th annual meeting of the American Thoracic Society showed that patients receiving Biaxin XL achieved a clinical cure rate of 88 percent, similar to those taking the quinolone, Levaquin, who achieved an 86 percent clinical cure rate.

Biaxin XL is the once-daily formulation of Abbott Laboratories widely prescribed, advanced-generation macrolide antibiotic, Biaxin(R)(clarithromycin tablets), and in March 2000 was approved by the U.S. Food and Drug Administration for the treatment of mild-to-moderate acute maxillary sinusitis and acute bacterial exacerbation of chronic bronchitis in adults. The efficacy and safety of Biaxin XL in treating other infections for which other formulations of Biaxin are approved have not been established.

These data are of interest because as many as three million Americans are affected each year by community-acquired pneumonia, said Dan Dattani, M.D., principal investigator, Prairie Clinical Research Group, assistant clinical professor of Family Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada, and lead investigator in this study. These data show that Biaxin and Levaquin had similar results in patients with this respiratory infection.

Study Results

Biaxin XL and Levaquin were compared in a double-blind, parallel-group, multicenter study in 299 ambulatory patients with CAP. Patients were randomized to receive either 1,000 mg of Biaxin XL (2 x 500mg tablets) once-a-day for seven days, or 500 mg of Levaquin (2 x 250mg tablets) once-a-day for seven days. Efficacy evaluations were made at the test-of-cure visit (seven to 14 days after compl

Contact: Tina Brookhouse
Porter Novelli

Page: 1 2 3 4

Related medicine news :

1. Chemists honor Heroes for biotechnology achievements in health
2. New data demonstrates that Benicar(R) and Benicar HCT (TM) achieve JNC 7 blood pressure goals
3. St. Jude helps South American community achieve improved survival rates for leukemia
4. New data shows Seroquel achieves remission in bipolar mania
5. ISHLT to recognize transplant pioneer Dr. Magdi Yacoub with lifetime achievement award
6. Study finds elderly patients achieve seizure freedom on epilepsy therapy
7. Researcher at UCLAs Jonsson Cancer Center wins lifetime achievement award
8. Children achieve sustained ADHD symptom improvement with long-term, once-daily use of Adderall XR
9. Birth weight and social class linked to educational achievement
10. Effexor (R) XR achieved long-term remission in 67 percent of recurring depression patients
11. Emory vaccine study in South Africa achieves significant reductions in pneumonia

Post Your Comments:

(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... NJ (PRWEB) , ... October 13, 2017 , ... Global ... at scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global ... physical activity. The fun run is geared towards children of all ages; it ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, ... lowdown on sciatica in a new episode of "Success Files," which is an ... and innovation and investigates each subject in-depth with passion and integrity. , Sciatica ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... ... October 12, 2017 , ... First ... compliance program management, will showcase a range of technology and learning solutions at ... (NCAL) Convention and Expo to be held October 14–18, 2017 at the Mandalay ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
(Date:9/28/2017)... WASHINGTON , Sept. 28, 2017 Cohen ... to advance the use of wearable and home sensors ... brain disorders. Early Signal Foundation, a nonprofit organization focused ... populations, will provide an affordable analytical system to record ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology:
Cached News: